We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The newly re-elected UK government has pledged to continue to expand
the role of the private sector in the country's socialised medicine system,
the National Health Service (NHS).
While regulatory standards in Hong Kong's pharmaceuticals sector are notably
higher than in many nearby markets, ethical drug producers continue to cite
serious failings.
One of Scotland's most advanced pharmaceutical factories could be facing closure
following a decision by its Netherlands-based owner to put it up for sale.
Results of a major trial of hormone therapy on men with locally advanced prostate
cancer announced today were a significant development and would be welcomed
by patients and oncologists world-wide, according to The Cancer Council Australia.
Sumitomo Pharmaceuticals announced that it has signed a licensing agreement
with Protez Pharmaceuticals for SMP-601, Sumitomo's proprietary antibiotic candidate.
Max India Group company Neeman Medical International entered into a strategic
partnership with Instituto Centroamericano De Investigaciones Clinicas (ICIC)
of Nicaragua for providing clinical trial services to pharmaceutical companies
in Nicaragua.
GlaxoSmithKline (GSK), the
British pharmaceutical concern, has submitted a complaint to the European Human
Rights Tribunal in Strasbourg and the Constitutional Tribunal in Poland, connected
with the import of medicines.
Previously rare criticism of South Africa's HIV/AIDS policy from
within the ruling ANC political party is growing, with two veteran legislators
the latest to voice opposition to controversial vitamin-based therapies.
According to Brazilian industry federation Febrafarma, the
country's drug market expanded by 17.67% in 2004, reaching a value of BRL19.8bn
(US$8.11bn).